274results about How to "Prevent elution" patented technology

The present invention provides a stent for delivering drugs to a vessel in a body, including a stent framework with a plurality of micropore reservoirs formed therein using a femtosecond laser, a drug polymer positioned in the reservoirs, and a polymer layer positioned on the drug polymer. The present invention also provides a method of manufacturing a drug-polymer stent and a method of treating a vascular condition using the drug-polymer stent.

A vascular stent comprising a drug-eluting outer layer of a porous sputtered columnar metal having each column capped with a biocompatible carbon-containing material is described. This is done by placing the stent over a close-fitting mandrel and rotating the assembly in a sputter flux. The result is a coating that is evenly distributed over the outward-facing side of the stent's wire mesh while preventing the sputtered columnar coating from reaching the inward facing side where a smooth hemocompatible surface is required. The stent is then removed from the mandrel, exposing all surfaces, and finally coated with a layer of carbon such as amorphous carbon or diamond-like carbon. The carbonaceous coating enhances biocompatibility without preventing elutriation of a therapeutic drug provided in the porosity formed between the columnar structures. The result is a stent that is adapted to both the hemodynamic and the immune response requirements of its vascular environment.

An object of the present invention is to provide a practical ophthalmic lens which has an effect of effectively retaining and sustainedly releasing a drug and has form stability before and after release of the drug, wherein the ionic polymer gel having sustained drug releasability can regulate the amount of the drug included therein, depending on the efficacy of the drug used, and storing solution for a practical ophthalmic lens. The present invention relates to a drug delivery ophthalmic lens comprising a cationic group-containing drug in the inside of a copolymer consisting of a hydrophilic monomer having a hydroxyl group in its molecule, at least one member selected from specific phosphate group-containing methacrylates a monomer having a nitrogen atom in its side chain, and a monomer copolymerizable with these components, and also relates to a drug delivery ophthalmic lens comprising an anionic group-containing drug in the inside of a copolymer consisting of a hydrophilic monomer, cationic and anionic monomers, and a monomer copolymerizable with these components, wherein the copolymer contains the anionic monomer in a ratio of 30 to 90 mol % to the cationic monomer, and also relates to storing solution for a practical ophthalmic lens.

With respect to a photoelectric conversion device comprising a semiconductor electrode composed of semiconductor fine particles and a metal film to be an opposite electrode, a polyethylene dioxythiophene (PEDOT)/polystyrenesulfonic acid (PSS) film is formed by spin coating on a transparent electrode of a metal oxide such as ITO to remarkably improve the adhesion property of the metal film to the metal oxide film and the pollution by the different type metal of the metal film to be the opposite electrode can be prevented in the photoelectric conversion device. Further, a semiconductor electrode composed of semiconductor fine particles can be formed well on the metal oxide film by low temperature process while elution of the metal oxide film is prevented to obtain the photoelectric conversion device.

The present invention provides a technology of inhibiting the decomposition of the solvent of the electrolyte solution for the secondary battery. Further, the present invention provides a technology of prohibiting the resistance increase of the secondary battery and improving the storage properties such as improving the capacity retention ratio. The electrolyte solution 15 comprising non-proton solvent and cyclic sulfonic ester including at least two sulfonyl groups may be used.

In an ion elution unit, a drive circuit applies a voltage between electrodes to elute metal ions from the electrodes. Polarities of the electrodes are reversed cyclically with a voltage application halt period placed in-between. A current detection circuit detects the current flowing between the electrodes. A check of operation of the current detection circuit is carried out before the application of a voltage to the electrodes is started. The operation of the current detection circuit is started when a predetermined period of time passes after the application of a voltage to the electrodes is started.

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices.

Methods of making a wear and oxidation resistant medical implant are disclosed.

A multilayer ceramic capacitor includes a ceramic main body including an inner layer portion including third ceramic layers and a plurality of inner electrodes arranged at interfaces between the third ceramic layers, and first and second outer layer portions respectively including first and second ceramic layers, the first and second ceramic layers being arranged vertically so as to sandwich the inner layer portion. The third ceramic layers and the first and second outer layer portions contain a perovskite-type compound represented by ABO₃ where A contains one or more of Ba, Sr, and Ca, B contains one or more of Ti, Zr, and Hf, and O represents oxygen) as a main component. Where a rare-earth element concentration (C_R) in the third ceramic layers is compared to a rare-earth element concentration (C_r) in outermost layer portions including at least outermost surfaces of the first and second outer layer portions, C_R>C_r (inclusive of C_r=0).

A heteropoly acid / ordered meso-porous silicon oxide catalyst used for removing the S-contained benzothiophenium compounds from the fractional oil of petroleum is prepared through such steps as dissolving heteropoly acid in the mixture of absolute alcohol and distilled water, adding ethyl n-silicate, magnetic stirring to obtain solution A, dissolving the polyoxyethene-polyoxypropene-polyoxyethene triblock copolymer in the mixture of absolute alcohol and distilled water to obtain solution B, slowly adding B to A, magnetic stirring to obtain sol, culturing it at 38-42 deg.C for 6-8 days, pulverizing, and calcining in N2.

A pulse charge method for a nonaqueous electrolyte secondary battery, includes: a charge control step of pulse charging by supplying a pulsed current periodically to the nonaqueous electrolyte secondary battery; a battery voltage detection step of measuring a battery voltage of the nonaqueous electrolyte secondary battery; a comparison step of comparing the battery voltage, measured in the battery voltage detection step when the pulsed current is supplied, with a predetermined set voltage; and a charge end control step of ending the pulse charging when a comparison result shows that the measured battery voltage is equal to or higher than the set voltage.

A feed additive composition includes a protective agent, lecithin in an amount of 0.05 to 6% by weight relative to a total weight of the composition, a basic amino acid in an amount of at least 40% by weight and less than 65% by weight relative to the total weight of the composition, and water. A method of producing a feed additive composition includes preparing a molten mixture of at least one protective agent, lecithin and at least one basic amino acid, and solidifying the molten mixture by immersing the molten mixture in water or an aqueous liquid. The protective agent includes hydrogenated vegetable oils and/or hydrogenated animal oils having melting points of greater than 50° C. and less than 90° C.

The present invention relates to lithium manganate particles having a primary particle diameter of 1 to 8 μm and forming substantially single-phase particles, which have a composition represented by the following chemical formula:

Li_1+xMn_2−x−yY1_yO₄+Y2

in which Y1 is at least one element selected from the group consisting of Ni, Co, Mg, Fe, Al, Cr and Ti; Y2 is P and is present in an amount of 0.01 to 0.6 mol % based on Mn; and x and y satisfy 0.03≦x≦0.15 and 0.05≦y≦0.20, respectively, and

• • which lithium manganate particles have a specific surface area of the lithium manganate particles of 0.3 to 0.9 m²/g (as measured by BET method); and have an average particle diameter (D₅₀) of the lithium manganate particles of 3 to 10 μm. A positive electrode active substance of a lithium ion secondary battery using the lithium manganate particles of the present invention has a high output and is excellent in high-temperature stability.

There is provided a production process of an electroluminescent element, which, even when a buffer layer patterned by a photolithographic process is formed, luminescence failure derived from cross contamination or a variation in film thickness does not take place and can realize high production efficiency. The production process comprises repeating at least twice the step of forming an electroluminescent layer comprising a buffer layer and a luminescent layer by patterning using a photolithographic process, thereby producing an electroluminescent element comprising a patterned electroluminescent layer, and comprises the steps of forming a first pattern part comprising a first buffer layer as the lowermost layer; and coating a solution for second buffer layer formation in a region including said first pattern part, the first buffer layer being immiscible with said solution for second buffer layer formation.

A non-aqueous electrolyte can suppress decomposition of a solvent, improve the cycle life of a secondary battery, suppress the rise of resistance of a secondary battery and improve the capacity maintenance ratio of a secondary battery A non-aqueous electrolyte secondary battery formed by using such a non-aqueous electrolyte includes a non-aqueous electrolyte containing an aprotic solvent and a disulfonic acid ester as expressed by chemical formula 1 shown below, a positive electrode and a negative electrode:

Provided is a method for forming a Cu wiring that does not cause Cu elution during CMP when a Ru material is used as a barrier metal film for the Cu wiring. The method has a step (d) of removing a second barrier metal film (Ru film) formed on a first barrier metal film on an upper surface of an interlayer insulating film, and a step (e) of depositing a seed copper (Cu) film on the first and the second barrier metal films after the step (d). By removing the second barrier metal film on the upper surface before the seed copper film is formed, copper is prevented from eluding into a slurry due to a battery effect of the second barrier metal film and copper.